Takara Bio Inc banner

Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 144 JPY 0.09% Market Closed
Market Cap: ¥137.8B

Wall St Price Targets

Price Targets Summary
Takara Bio Inc

Wall Street analysts forecast Takara Bio Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 714 JPY with a low forecast of 707 JPY and a high forecast of 735 JPY.

Lowest Forecast
Price Target
707 JPY
38% Downside
Average Forecast
Price Target
714 JPY
38% Downside
Highest Forecast
Price Target
735 JPY
36% Downside
Takara Bio Inc Competitors:
Price Targets
VERK
Verkkokauppa.com Oyj
1% Upside
NCSM
NCS Multistage Holdings Inc
32% Upside
CFFN
Capitol Federal Financial Inc
4% Upside
QTTB
Homology Medicines Inc
13% Upside
FLB
Fluidigm Corp
110% Upside
ADSK
Autodesk Inc
62% Upside

Revenue
Forecast

7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 2%.

Gross Profit
Forecast

7% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 0%.

Operating Income
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Takara Bio Inc

Pre-Tax Income
Forecast

1% / Year
Past Growth
-30% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
1% / Year
Past Growth
-30% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is -30%.

Net Income
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 0%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Takara Bio Inc's stock price target?
Price Target
714 JPY

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 714 JPY with a low forecast of 707 JPY and a high forecast of 735 JPY.

What is the Revenue forecast for Takara Bio Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 2%.

What is the Gross Profit forecast for Takara Bio Inc?
Projected CAGR
0%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 0%.

What is the Pre-Tax Income forecast for Takara Bio Inc?
Projected CAGR
-30%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is -30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett